Monopar Therapeutics Inc (MNPR) — Financial Flexibility Index
Monopar Therapeutics Inc (MNPR) has a Financial Flexibility Index of -1.34x as of March 2026. Free cash flow of $-3.47 Million (operating CF $-3.47 Million minus capex $4.00) represents -1% of total liabilities ($2.59 Million). Check Monopar Therapeutics Inc (MNPR) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Monopar Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Monopar Therapeutics Inc across 11 annual periods. See Monopar Therapeutics Inc (MNPR) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Monopar Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Monopar Therapeutics Inc. For the full company profile including market capitalisation, see Monopar Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.22x | $-12.20 Million | $-12.20 Million | $2.89 Million | ▼ -246.4% |
| 2024 | -1.22x | $-6.40 Million | $-6.40 Million | $5.25 Million | ▲ +72.7% |
| 2023 | -4.47x | $-7.86 Million | $-7.86 Million | $1.76 Million | ▼ -94.1% |
| 2022 | -2.30x | $-7.23 Million | $-7.23 Million | $3.14 Million | ▲ +50.2% |
| 2021 | -4.63x | $-7.32 Million | $-7.32 Million | $1.58 Million | ▼ -16.8% |
| 2020 | -3.96x | $-4.66 Million | $-4.66 Million | $1.18 Million | ▲ +4.9% |
| 2019 | -4.17x | $-3.02 Million | $-3.02 Million | $724.16K | ▲ +42.3% |
| 2018 | -7.23x | $-2.89 Million | $-2.89 Million | $399.55K | ▲ +14.2% |
| 2017 | -8.42x | $-2.63 Million | $-2.63 Million | $311.87K | ▲ +54.5% |
| 2016 | -18.52x | $-1.19 Million | $-1.19 Million | $64.51K | ▼ -114.9% |
| 2015 | -8.62x | $-636.33K | $-636.33K | $73.84K | — |